Eden pairs predictable flat-rate pricing with a broad medication menu. No membership fee, a flat price across doses, free expedited shipping, and both semaglutide (injection or oral) and tirzepatide are real strengths. The offsets are async, no-labs care with lighter oversight, a pharmacy it does not specifically name, a newer and smaller review base, and first-month promo pricing that rises afterward.
Eden at a glance
- Category:
- Telehealth weight-loss (GLP-1)
- Medication:
- Compounded semaglutide & tirzepatide (not FDA-approved)
- Semaglutide:
- ~$229/mo · first month ~$149 (verify; some sources ~$239)
- Tirzepatide:
- ~$329/mo
- Membership fee:
- None — flat-rate pricing
- Pharmacy:
- U.S.-licensed 503A; specific partner not named (verify)
- Labs:
- Not required
- Rating:
- Rating pending verification
- Clinical model:
- Async telehealth · same-day approvals
Pros and cons
What we like
- Flat-rate pricing with no membership fee
- Both semaglutide (injection or oral) and tirzepatide
- Free expedited shipping; fast, same-day approvals
- Predictable monthly cost
- No labs required to start
Trade-offs to know
- Does not pre-disclose a specific compounding pharmacy
- Async care with no labs — lighter clinical oversight
- Newer, smaller review base than incumbents
- First-month promo pricing rises afterward
- Tirzepatide relatively pricey vs low-cost peers
- Medication is compounded — not FDA-approved
Scorecard
Scored on the same five-criterion rubric we apply to every provider. Weights in parentheses.
Pricing: flat-rate, promo first month
Eden uses flat-rate pricing with no membership fee. Compounded semaglutide runs about $229/mo with a discounted first month around $149, and compounded tirzepatide about $329/mo. Some sources cite a true monthly semaglutide price closer to $239, and pricing varies by plan, so treat the first-month figure as a promo that rises afterward. Tirzepatide sits on the pricier side relative to the lowest-cost peers. Verify current pricing on tryeden.com before deciding.
Pharmacy & sourcing
Eden says it uses U.S.-licensed 503A compounding pharmacies, but it does not pre-disclose a specific pharmacy partner. Because compounded drugs are not FDA-approved, the pharmacy is the primary quality signal, so an unnamed pharmacy removes a key way for patients to verify sourcing and request a certificate of analysis. This weighs on Eden's pharmacy-disclosure score. Verify current pharmacy details directly with Eden.
Reviews & reputation
We have not verified Eden's third-party rating to a primary source, so we show its rating as pending verification rather than publish an unconfirmed number. Eden has a smaller review history than incumbents, and sources including ConsumerAffairs and US News list complaints alongside positive feedback. A smaller sample means individual reviews carry more weight, so read recent ones and check current listings before deciding.
Clinical model
Eden runs an async telehealth model with fast, same-day approvals and no labs required. That's convenient, but no-labs async care offers lighter oversight than programs built around live visits or baseline labs. As with any GLP-1 program, a licensed clinician determines whether treatment is appropriate; medication is not guaranteed and individual results vary.
Who Eden is best for
Choose Eden if you want flat-rate pricing with no membership, free expedited shipping, and the option of oral or injectable semaglutide, with fast, no-labs approvals. Consider another provider if you want a larger review base and live-clinician oversight alongside a named pharmacy — compare all ten in the full rankings.
Eden FAQ
How much does Eden really cost?
Eden charges flat-rate pricing with no membership fee: compounded semaglutide is about $229/mo (with a discounted first month around $149) and compounded tirzepatide about $329/mo. Some sources cite a true monthly semaglutide price closer to $239, and pricing varies by plan, so verify current pricing on tryeden.com.
Does Eden name its compounding pharmacy?
Not specifically. Eden says it uses U.S.-licensed 503A compounding pharmacies but does not pre-disclose a specific pharmacy partner. Because compounded drugs are not FDA-approved, an unnamed pharmacy removes a key way to verify sourcing. Verify current pharmacy details with Eden.
Is Eden FDA-approved?
Eden's compounded semaglutide and tirzepatide are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. Compounded semaglutide is not Ozempic® or Wegovy®; compounded tirzepatide is not Mounjaro® or Zepbound®.